Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
You should never reconstitute two different peptides in the same vial or mix them in the same syringe unless a specific protocol has validated their stability together
Serious side effects are less common but may include pancreatitis, gallbladder problems, kidney problems related to dehydration, severe stomach problems, allergic reactions, low blood sugar in people with type 2 diabetes, vision changes, and a possible risk of thyroid tumors
Blood pressure: Systolic BP reduction of ~17 mmHg, clinically relevant in patients with cardiometabolic risk
Triple agonism addresses more of the obesity puzzle than single agonism
Some researchers think that slower digestion could lead to different patterns of bacterial growth in the intestines, although more research is needed to confirm this link with yeast infections
![Efficacy of tirzepatide in phase 2 (GPGB; [14]) and phase 3 (SURPASS-1](https://www.researchgate.net/publication/363201315/figure/fig3/AS:11431281082605778@1662084799021/Efficacy-of-tirzepatide-in-phase-2-GPGB-14-and-phase-3-SURPASS-1-to-5-15-19.png)
